€11 billion down: how Italian pharma has been eroded
This article was originally published in Scrip
Executive Summary
In a letter sent on 23 July to Prime Minister Mario Monti and Finance Minister Vittorio Grilli the pharma and biotech industry in Italy outlined the gloomy consequences for the country's drug market of the government actions or inactions over the past decade. And there could be worse to come, the Italian biotech industry association, Assobiotec, told Scrip.